BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17725605)

  • 1. Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours.
    Manning J; Indrova M; Lubyova B; Pribylova H; Bieblova J; Hejnar J; Simova J; Jandlova T; Bubenik J; Reinis M
    Immunology; 2008 Feb; 123(2):218-27. PubMed ID: 17725605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes.
    Vlková V; Štěpánek I; Hrušková V; Šenigl F; Mayerová V; Šrámek M; Šímová J; Bieblová J; Indrová M; Hejhal T; Dérian N; Klatzmann D; Six A; Reiniš M
    Oncotarget; 2014 Aug; 5(16):6923-35. PubMed ID: 25071011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules.
    Smahel M; Síma P; Ludvíková V; Marinov I; Pokorná D; Vonka V
    Vaccine; 2003 Mar; 21(11-12):1125-36. PubMed ID: 12559790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status.
    Símová J; Polláková V; Indrová M; Mikyšková R; Bieblová J; Stěpánek I; Bubeník J; Reiniš M
    Br J Cancer; 2011 Nov; 105(10):1533-41. PubMed ID: 22015556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors.
    Setiadi AF; Omilusik K; David MD; Seipp RP; Hartikainen J; Gopaul R; Choi KB; Jefferies WA
    Cancer Res; 2008 Dec; 68(23):9601-7. PubMed ID: 19047136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells.
    Khan AN; Gregorie CJ; Tomasi TB
    Cancer Immunol Immunother; 2008 May; 57(5):647-54. PubMed ID: 18046553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
    Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
    Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.
    Ritz U; Momburg F; Pilch H; Huber C; Maeurer MJ; Seliger B
    Int J Oncol; 2001 Dec; 19(6):1211-20. PubMed ID: 11713591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma.
    Ritter C; Fan K; Paschen A; Reker Hardrup S; Ferrone S; Nghiem P; Ugurel S; Schrama D; Becker JC
    Sci Rep; 2017 May; 7(1):2290. PubMed ID: 28536458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin.
    Seliger B; Wollscheid U; Momburg F; Blankenstein T; Huber C
    Tissue Antigens; 2000 Oct; 56(4):327-36. PubMed ID: 11098932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells.
    Chou SD; Khan AN; Magner WJ; Tomasi TB
    Int Immunol; 2005 Nov; 17(11):1483-94. PubMed ID: 16210330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of unmethylated CpG oligodeoxynucleotides on MHC class I-deficient and -proficient HPV16-associated tumours.
    Reinis M; Símová J; Bubeník J
    Int J Cancer; 2006 Apr; 118(7):1836-42. PubMed ID: 16217768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with MHC class I-negative but not -positive HPV16-associated tumour cells inhibits growth of MHC class I-negative tumours.
    Reinis M; Símová J; Indrová M; Bieblová J; Pribylová H; Moravcová S; Jandlová T; Bubeník J
    Int J Oncol; 2007 Apr; 30(4):1011-7. PubMed ID: 17332942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
    Indrová M; Bieblová J; Jandlová T; Vonka V; Pajtasz-Piasecka E; Reinis M
    Int J Oncol; 2006 Jan; 28(1):253-9. PubMed ID: 16328003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.
    Romero I; Martinez M; Garrido C; Collado A; Algarra I; Garrido F; Garcia-Lora AM
    J Pathol; 2012 Jul; 227(3):367-79. PubMed ID: 22451343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.
    Morimoto Y; Toyota M; Satoh A; Murai M; Mita H; Suzuki H; Takamura Y; Ikeda H; Ishida T; Sato N; Tokino T; Imai K
    Br J Cancer; 2004 Feb; 90(4):844-52. PubMed ID: 14970863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation.
    Zheng P; Guo Y; Niu Q; Levy DE; Dyck JA; Lu S; Sheiman LA; Liu Y
    Nature; 1998 Nov; 396(6709):373-6. PubMed ID: 9845074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition.
    Pellicciotta I; Cortez-Gonzalez X; Sasik R; Reiter Y; Hardiman G; Langlade-Demoyen P; Zanetti M
    Cancer Res; 2008 Oct; 68(19):8085-93. PubMed ID: 18829567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.